Cancer Exome Analysis Reveals a T Cell Dependent Mechanism of Cancer Immunoediting
暂无分享,去创建一个
E. Mardis | D. Koboldt | M. Wendl | V. Magrini | R. Schreiber | T. Wylie | R. Demeter | J. Allison | L. Old | M. Smyth | J. White | M. Vesely | J. Hundal | C. Arthur | H. Matsushita | C. Rickert | R. Uppaluri | Yee-Shiuan Chen | Lauren K. Shea | L. Shea | Yee Shiuan Chen | Ryan T. Demeter | Hirokazu Matsushita | Mark J. Smyth | Mark J Smyth
[1] T. Jacks,et al. Expression of tumour-specific antigens underlies cancer immunoediting , 2011, Nature.
[2] Juliane C. Dohm,et al. Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia , 2011, Nature.
[3] Hidenori Ojima,et al. High-resolution characterization of a hepatocellular carcinoma genome , 2011, Nature Genetics.
[4] R. Schreiber,et al. Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion , 2011, Science.
[5] R. Schreiber,et al. Natural innate and adaptive immunity to cancer. , 2011, Annual review of immunology.
[6] Helga Thorvaldsdóttir,et al. Integrative Genomics Viewer , 2011, Nature Biotechnology.
[7] A. Sparks,et al. The mutation spectrum revealed by paired genome sequences from a lung cancer patient , 2010, Nature.
[8] Joshua F. McMichael,et al. Genome Remodeling in a Basal-like Breast Cancer Metastasis and Xenograft , 2010, Nature.
[9] E. Birney,et al. A small cell lung cancer genome reports complex tobacco exposure signatures , 2009, Nature.
[10] Tom Royce,et al. A comprehensive catalogue of somatic mutations from a human cancer genome , 2010, Nature.
[11] Ryan D. Morin,et al. Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution , 2009, Nature.
[12] Ken Chen,et al. VarScan: variant detection in massively parallel sequencing of individual and pooled samples , 2009, Bioinform..
[13] Gonçalo R. Abecasis,et al. The Sequence Alignment/Map format and SAMtools , 2009, Bioinform..
[14] Richard Durbin,et al. Sequence analysis Fast and accurate short read alignment with Burrows – Wheeler transform , 2009 .
[15] Amy E. Hawkins,et al. DNA sequencing of a cytogenetically normal acute myeloid leukemia genome , 2008, Nature.
[16] K. Kinzler,et al. Epitope landscape in breast and colorectal cancer. , 2008, Cancer research.
[17] Lloyd J. Old,et al. Adaptive immunity maintains occult cancer in an equilibrium state , 2007, Nature.
[18] Jan Grimm,et al. A spatially and temporally restricted mouse model of soft tissue sarcoma , 2007, Nature Medicine.
[19] J. Yewdell,et al. Confronting complexity: real-world immunodominance in antiviral CD8+ T cell responses. , 2006, Immunity.
[20] Thierry Boon,et al. Human T cell responses against melanoma. , 2006, Annual review of immunology.
[21] R. DePinho,et al. Endogenous oncogenic K-ras(G12D) stimulates proliferation and widespread neoplastic and developmental defects. , 2004, Cancer cell.
[22] R. Schreiber,et al. The three Es of cancer immunoediting. , 2004, Annual review of immunology.
[23] T. Hubbard,et al. A census of human cancer genes , 2004, Nature Reviews Cancer.
[24] O. Lund,et al. novel sequence representations Reliable prediction of T-cell epitopes using neural networks with , 2003 .
[25] N. Restifo,et al. Natural selection of tumor variants in the generation of “tumor escape” phenotypes , 2002, Nature Immunology.
[26] R. Schreiber,et al. Cancer immunoediting: from immunosurveillance to tumor escape , 2002, Nature Immunology.
[27] J. Mullikin,et al. SSAHA: a fast search method for large DNA databases. , 2001, Genome research.
[28] R. Schreiber,et al. IFNγ and lymphocytes prevent primary tumour development and shape tumour immunogenicity , 2001, Nature.
[29] G. Peltz,et al. GATA-3-dependent enhancer activity in IL-4 gene regulation. , 1998, Journal of immunology.
[30] R. Schreiber,et al. Enhanced in vivo growth and resistance to rejection of tumor cells expressing dominant negative IFN gamma receptors. , 1994, Immunity.
[31] M Aguet,et al. Functional role of type I and type II interferons in antiviral defense. , 1994, Science.
[32] R. Zinkernagel,et al. Immune response in mice that lack the interferon-gamma receptor. , 1993, Science.
[33] P. Chomez,et al. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. , 1991, Science.
[34] H. Herschman,et al. Tumorigenic methylcholanthrene transformants of C3H/10T1/2 cells have a common nucleotide alteration in the c-Ki-ras gene. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[35] Old Lj,et al. Immunology of Experimental Tumors , 1964 .
[36] L. Old,et al. IMMUNOLOGY OF EXPERIMENTAL TUMORS. , 1964, Annual review of medicine.
[37] R. Prehn,et al. Immunity to methylcholanthrene-induced sarcomas. , 1957, Journal of the National Cancer Institute.